Brendan Lau has a $4.74 target for EBT
"I reiterate my “outperform” recommendation on the stock with a price target of $4.74 a share."
Personally, i prefer to base my investment decisions on profit, not revenue. While revenue may fall (normalised) profit is forecast to increase as a result.
"The agreement provides service and technology revenue certainty and, as a consequence, whilst lowering sales revenue at the top line, will increase profitability and therefore will be earnings accretive."
Add to My Watchlist
What is My Watchlist?